KB
CMD

Kimelman & Baird’s Cantel Medical Corporation CMD Stock Holding History

Kimelman & Baird’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$14.5M Sell
194,157
-3,660
-2% -$310K 2.01% 22
2019
Q2 		$16M Buy
197,817
+651
+0.3% +$45.8K 2.22% 19
2019
Q1 		$13.2M Sell
197,166
-6,499
-3% -$492K 1.9% 23
2018
Q4 		$15.2M Sell
203,665
-2,976
-1% -$246K 2.36% 17
2018
Q3 		$19M Buy
206,641
+499
+0.2% +$47.5K 2.4% 16
2018
Q2 		$20.3M Buy
+206,142
New +$23.1M 2.66% 12
2017
Q4 		$23M Sell
223,982
-91
-0% -$9.06K 3.28% 9
2017
Q3 		$21.1M Sell
224,073
-25
-0% -$1.97K 3.15% 9
2017
Q2 		$17.5M Sell
224,098
-124,543
-36% -$9.35M 2.65% 11
2017
Q1 		$27.9M Sell
348,641
-11,983
-3% -$952K 4.25% 4
2016
Q4 		$28.4M Sell
360,624
-9,043
-2% -$703K 4.76% 4
2016
Q3 		$28.8M Sell
369,667
-2,644
-0.7% -$192K 5.07% 3
2016
Q2 		$25.6M Sell
372,311
-27,500
-7% -$1.9M 4.68% 4
2016
Q1 		$28.5M Buy
399,811
+7,074
+2% +$444K 5.33% 3
2015
Q4 		$24.4M Buy
+392,737
New +$24M 4.59% 5
2015
Q2 		$25.5M Sell
474,285
-34,057
-7% -$1.66M 4.34% 3
2015
Q1 		$24.1M Sell
508,342
-12,025
-2% -$532K 4.4% 4
2014
Q4 		$22.5M Buy
520,367
+39,100
+8% +$1.6M 4.06% 5
2014
Q3 		$16.5M Sell
481,267
-51,844
-10% -$1.83M 3.13% 6
2014
Q2 		$19.5M Sell
533,111
-26,497
-5% -$899K 3.44% 6
2014
Q1 		$18.9M Buy
559,608
+20,818
+4% +$687K 3.52% 7
2013
Q4 		$18.3M Sell
538,790
-10,105
-2% -$350K 3.5% 6
2013
Q3 		$17.5M Buy
548,895
+2,124
+0.4% +$56.5K 3.49% 4
2013
Q2 		$12.3M Buy
+546,771
New +$11.8M 2.6% 8

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Kimelman & Baird's CMD Position: Q3 2019 in Review

Kimelman & Baird reduced its Cantel Medical Corporation (CMD) stake by 1.9% in Q3 2019, selling an estimated $310K and leaving 194,157 shares worth $14.5M. The position accounts for 2.01% of the portfolio, ranked #22.

Kimelman & Baird first reported a position in CMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $28.8M in Q3 2016. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Kimelman & Baird held 194,157 shares of Cantel Medical Corporation worth $14.5M as of Q3 2019.
  • Kimelman & Baird sold 3,660 Cantel Medical Corporation shares in Q3 2019, an estimated $310K.
  • Cantel Medical Corporation made up 2.01% of Kimelman & Baird's portfolio in Q3 2019, its #22 holding.
  • Kimelman & Baird first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 24 quarters since.
  • Kimelman & Baird's Cantel Medical Corporation position peaked at $28.8M in Q3 2016.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Kimelman & Baird's 13F filing for Q3 2019, filed 10 Dec 2019.